Acumen Pharmaceuticals, Inc. (ABOS) vs Armata Pharmaceuticals, Inc. (ARMP)

Acumen Pharmaceuticals, Inc. and Armata Pharmaceuticals, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Armata Pharmaceuticals, Inc. are of similar size ($120.8M and $114.9M). Acumen Pharmaceuticals, Inc. has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 15 metrics below, Acumen Pharmaceuticals, Inc. leads on 9 and Armata Pharmaceuticals, Inc. on 6.

Valuation

Metric ABOS ARMP Biotechnology median
P/E n/m n/m 8.50
P/S 85.03 22.01 9.71
P/B 2.13 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 30.28 68.84 9.21
Earnings yield (96.45%) (159.94%) (33.15%)
Free cash flow yield (75.24%) (21.14%) (25.50%)

Profitability

Metric ABOS ARMP Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (734.19%) 0.00%
Net margin 0.00% (3,467.04%) 0.00%
Free cash flow margin 0.00% (465.34%) 0.00%
Return on equity (120.50%) 127.83% (56.36%)
Return on assets (72.97%) (225.11%) (48.04%)
Return on invested capital 0.00% (89.61%) 0.00%

Growth

Metric ABOS ARMP Biotechnology median
Revenue growth (TTM) — (19.29%) 6.02%
EPS growth (last fiscal year) (16.96%) (1,398.60%) 30.26%
Revenue growth, 5-year CAGR — 42.90% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS ARMP Biotechnology median
Debt to equity 0.55 (1.23) 0.00
Current ratio 2.47 0.11 4.72
Net debt to EBITDA 0.69 (7.07) 0.96

Dividend

Metric ABOS ARMP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABOS ARMP Biotechnology median
Market cap 120.77m 114.90m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack